Delivery Order SPE2DB22D9353-SPE2DB25FX2BZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,540.68 to DMS Pharmaceutical Group Inc. for the supply of EYLEA 2 mg/0.05 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, is for pharmaceutical products to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a $11,887.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The award was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical Group will perform...
- The Defense Logistics Agency awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on August 18, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order was issued without a set-aside designation and is set to be completed by September 9, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials valued at $198,126.00. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million and valid through November 2026, which enables the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,925.08 on July 29, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This award is funded by the Department of Defense through its Medical Supply Chain function and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Eylea HD 8 mg/0.07 ml vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of August 27, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BZDelivery Order
On August 12, 2025, the Defense Logistics Agency awarded a delivery order valued at $5,943.78 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 ml vials. This firm fixed-price delivery order, issued without a set-aside designation, is scheduled for completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and sole awardee on this engagement. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products to support medical supply requirements across Department of Defense healthcare facilities worldwide. EYLEA HD, an ophthalmic medication, represents one category within the extensive portfolio of branded pharmaceuticals, generic medications, biologics, and medical consumables that DMS Pharmaceutical Group delivers to military and federal healthcare systems as part of its core federal contracting operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/12/25 |